Axitinib, cabozantinib, or everolimus in the treatment of prior sunitinib-treated patients with metastatic renal cell carcinoma: results of matching-adjusted indirect comparison analyses

Overview of attention for article published in BMC Cancer, December 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 19 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,327 followers.

RT @evideraglobal: Discover the results from an indirect comparison of the relative efficacy between three renal cell carcinoma therapies i…

14 Feb 2019

Reply Repost Favourite

Discover the results from an indirect comparison of the relative efficacy between three renal cell carcinoma therapies in sunitib-treated patients using data from the AXIS and METEOR trials in this study #MAIC: https://t.co/hpQ4ja7Gg7 https://t.co/FSSnGm2s

11 Feb 2019

Reply Repost Favourite